Biosimilarity isn’t discovered. It’s engineered.
Precision in every molecule.
Your pure-play
biosimilar developer with an
international track record.
Built to accelerate biosimilar pipelines.
Approved biosimilars
8
Years biologics expertise
12+
Regulatory standards
EMA · FDA
Partners worwide
8
Operating from Zug
Switzerland
Global reach
EU · US · MENA +
WHAT WE DO
We produce impact
driven biosimilars. From
concept to end market.
that most biosimilar programs don’t fail on science. They fail at the transitions.
The molecule isn’t the risk.
The transitions are.
is to keep every program seemlessly moving as one system, from concept to commercial supply.
Full biosimilar lifecycle.
One global development strategy.
We know
Our goal
Swiss engineered, supplied globally
Why partners trust us.
key pillars
A foundation
for reach
We build every program to be regulatory-ready across geographies, giving our commercial partners the fastest possible path to their markets.
A clean track
record
Development pathways built on regulatory rigor, so partners commercialize with certainty. Every product we’ve brought to approval cleared without regulatory pushback.
Built for continuity
Coordinated manufacturing and distribution networks designed to keep supply steady, even at scale.
One point,
full orchestration
A single accountable partner coordinating best-in-class development, manufacturing and commercial supply — so partners can focus on getting products to market.
From concept
to commercial supply
We cover full biosimilar lifecycle
We cover the full biosimilar lifecycle
Momentum doesn't stall at the transitions that matter most.
Development
Designed for scale from day one
GMP manufacturing built for compliance
Tech transfer managed end-to-end
Clinical strategy, study planning, execution & reporting
Regulatory
One unified regulatory strategy
Dossier build for global submission.
Inspection readiness from the start
Commercial supply
Supply continuity built into the program
Launch planning across global markets
Operational risk managed proactively
Lifecycle management
Post-approval changes handled in-house
Label extensions and process updates
Accountable long after launch
Biosimilars don't move themselves. People move them. From molecule to end market.
If you are motivated by complex challenges and meaningful work, we invite you to join us.
Our people are at the heart
of our success.
We bring together scientists, engineers, quality experts, and business professionals who share a commitment to excellence and patient impact.
Biosimilars pipeline
Meet the team of experts
behind every program
Deep expertise. Lean by intention.
The right partner changes everything
Our partnerships are built on trust, ownership,
and long-term commitment.
